About
GoodCap Pharmaceuticals develops novel drug candidates targeting neuroinflammatory and psychiatric disorders, including PTSD, using proprietary molecular combinations and psychedelics-based innovations.
Explore GoodCap Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.